title: VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie Pédiatrique.
authors.affiliation: Centre L. Bérard, Lyon, France.
authors.forename: D
authors.initials: D
authors.lastname: Frappaz
authors.forename: J
authors.initials: J
authors.lastname: Michon
authors.forename: O
authors.initials: O
authors.lastname: Hartmann
authors.forename: E
authors.initials: E
authors.lastname: Bouffet
authors.forename: J C
authors.initials: JC
authors.lastname: Gentet
authors.forename: P
authors.initials: P
authors.lastname: Chastagner
authors.forename: E
authors.initials: E
authors.lastname: Sariban
authors.forename: L
authors.initials: L
authors.lastname: Brugière
authors.forename: H
authors.initials: H
authors.lastname: Rubie
authors.forename: O
authors.initials: O
authors.lastname: Lejars
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity*; D016190:Carboplatin / Q000008:administration & dosage / Q000633:toxicity*; D002675:Child, Preschool; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology
chemical_list: D005047:Etoposide; D016190:Carboplatin